Merck KGaA

The current price of MKKGY is $33.76 — it has decreased by 1.00% since the previous close. Data as of Nov 5, 2026.

MKKGY is down 0.32% over the past week, up 10.00% over the past month and up 32.91% over the past year. The price is above its 200-day moving average of $29.93.

Of the 2 analysts covering Merck KGaA, 1 rates it a strong buy and 1 rates it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Merck KGaA has a market capitalization of $73.39B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Merck KGaA posted earnings of $0.26 per share against an estimate of $0.47, missing expectations by 44.68%. Upcoming reports are listed in the earnings calendar.

Merck KGaA reported revenue of $6.27B in its most recent quarter, which has increased by 1.30% compared with the same quarter a year earlier. Analysts had expected $6.08B.

Yes. Merck KGaA pays dividends annually. The latest payment of $0.5148 per share has a payment date of May 6, 2026, which corresponds to a dividend yield of 1.97%.

Companies most comparable to Merck KGaA include Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Agilent Technologies, Inc. and Waters Corporation.

In the latest trading session MKKGY moved between $33.60 and $33.83, a range of 0.68% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Merck KGaA shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Merck KGaA is strong buy. Technical ratings are indicators, not investment advice.

Over the past 52 weeks MKKGY has traded between $23.73 and $34.19. The current price is 1.26% below its 52-week high.